G-Protein Coupled Receptors Market to Grow at a CAGR of 6.9% from 2025 to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The G-Protein Coupled Receptors Market Size During 2025–2029?

The g-protein coupled receptors market has experienced substantial expansion in recent years. This market is anticipated to expand from $3.2 billion in 2024 to $3.4 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.3%. Over the historic period, this growth can be attributed to several factors including advances in drug discovery, FDA approvals, genomic discoveries, the development of emerging markets, market consolidation, and a growing aging population.

The g-protein coupled receptors market size is forecast to demonstrate robust growth over the next few years. It is expected to achieve $4.44 billion by 2029, with a compound annual growth rate (CAGR) of 6.9%. This expansion throughout the forecast period stems from factors such as personalized medicine, a greater emphasis on rare diseases, the integration of artificial intelligence in drug discovery, patient-centric drug development, environmental and social considerations, and the rise of the biosimilar market. Noteworthy trends for the forecast period involve advancements in biotechnology, heightened investment in research and development, continuous technological innovations, strategic collaborations and partnerships, and the adoption of digital therapeutics.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11976&type=smp

Which Drivers Are Supporting Growth Of The G-Protein Coupled Receptors Market?

The increasing occurrence of cancer is projected to fuel expansion in the G-protein-coupled receptors market. Cancer is characterized by the uncontrolled proliferation of abnormal cells that can infiltrate nearby tissues. Additionally, cancer cells can disseminate throughout the body via the lymphatic and vascular systems. G-protein-coupled receptors (GPCRs) regulate fundamental cancer processes such as proliferative signaling, replicative immortality, evasion of growth suppressors, resistance to apoptosis, and the initiation of invasion and metastasis. For example, in January 2023, the American Cancer Society, a US-based professional organization, disclosed that 1,958,310 new cancer cases were identified in the United States in 2023. This figure represents an increase from the approximately 1.9 million new cases recorded in 2022. Consequently, the escalating incidence of cancer is a key factor boosting the G-protein coupled receptors market’s expansion.

What Are The Segment Types Shaping The G-Protein Coupled Receptors Market?

The g-protein coupled receptorsmarket covered in this report is segmented –

1) By Product: Cell Lines; Detection Kits; Cell Culture Reagents; Ligands

2) By Assay: CAMP Functional Assays; Calcium Functional Assays; ß-Arrestin Functional Assays; Radioligand Binding And GTP?S Functional Assays; Internalization Assays; Trafficking Assays

3) By Applications: Cancer Research; CNS Research; Metabolic Research; Cardiovascular Research; Inflammation Research; Respiratory Research; Other Applications

Subsegments:

1) By Cell Lines: GPCR-Expressing Cell Lines; Stable And Transient Cell Lines

2) By Detection Kits: ELISA Kits; High-Throughput Screening Kits; Reporter Gene Assays

3) By Cell Culture Reagents: Media And Supplements; Transfection Reagents; Growth Factors

4) By Ligands: Agonists; Antagonists; Inverse Agonists

Which Key Trends Are Expected To Influence The G-Protein Coupled Receptors Market In The Coming Years?

A prominent trend gaining traction in the G-protein-coupled receptor (GPCR) market is the increased investment aimed at enhancing GPCR screening and antibody development. Major companies within the GPCR sector are actively seeking funding to create drugs and medical technologies for GPCR-related diseases. For example, in February 2023, LifeArc Ventures, a UK-based venture capital firm, invested $16 million in Maxion Therapeutics, a UK-based drug discovery company. This investment is intended to advance antibody development for previously untreatable ion channel and GPCR-driven disorders. The funding will support the creation of antibody therapeutics that target ion channels and G-protein-coupled receptors (GPCRs) through the use of their proprietary KnotBody technology. The KnotBody platform enables the discovery of biological agents against ion channels and GPCRs, utilizing naturally occurring cysteine-rich mini proteins. Additionally, Septerna Inc., a US-based biotechnology company, announced its launch and secured $100 million in Series A financing. This Series A funding will be allocated to developing its emerging pipeline of innovative GPCR-targeted medication programs, which are powered by the Native Complex Platform and cover numerous therapeutic areas.

Who Are The Primary Competitors In The Global G-Protein Coupled Receptors Market?

Major companies operating in the G-protein coupled receptors market include Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline Plc, Danaher Corporation, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Thermo Fisher Scientific Inc., Perkin Elmer Inc., Qiagen N.V., Bio-Techne Corporation, Abcam PLC, Cara Therapeutics Inc., Sosei Heptares Ltd., Eurofins DiscoverX Corporation, Crinetics Pharmaceuticals Inc., Domain Therapeutics SA, Addex Pharmaceuticals Ltd., Escient Pharmaceuticals Inc., Structure Therapeutics, Septerna

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/g-protein-coupled-receptors-global-market-report

How Does The G-Protein Coupled Receptors Market Perform Across Key Geographic Regions?

North America was the largest region in the G-protein coupled receptors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the G-protein coupled receptors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The G-Protein Coupled Receptors Market Report:

https://www.thebusinessresearchcompany.com/customise?id=11976&type=smp

Browse Through More Reports Similar to the Global G-Protein Coupled Receptors Market 2025, By The Business Research Company

Chemicals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report

Chemicals By End Use Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chemicals-by-end-use-global-market-report

Adhesives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/adhesives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795